Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.

Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedUpdated page version to v3.2.0 and added a government operating status disclaimer; removed the specific medical term 'B-cell chronic lymphocytic leukemia' from the content.SummaryDifference2%

- Check33 days agoChange DetectedUpdated terminology and taxonomy for leukemia/lymphoma and infections, and bumped revision to v3.1.0; older specific leukemia terms were removed in favor of broader or updated classifications.SummaryDifference0.7%

- Check48 days agoChange DetectedRevision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.SummaryDifference0.1%

- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

- Check62 days agoChange DetectedThe web page has added significant information regarding drug treatments and genetic conditions related to various types of leukemia, while also removing several previous entries related to other diseases and treatments.SummaryDifference5%

- Check69 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.5%

Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.